Antimicrobial Resistance, Prescribing, and Consumption Data to Inform Country Antibiotic Guidance and Local Action – the ADILA project. (360G-Wellcome-222051_Z_20_Z)

The overall goal of this project is to develop simple tools to help individual countries make the best use of their own AMR surveillance data to inform local action. The project will use a range of modelling methods of existing global data sets that include information on clinical infection management and outcomes, antibiotic resistance, consumption and use. The proposal aims to learn from the development of clinical surveillance networks in other disease areas such as tuberculosis (TB) and will use a public health approach to provide a conceptual framework for future surveillance implementation and policy goals. This project combines research expertise on antimicrobial resistance, usage modelling and policy development. It aims to model the existing data sets to provide a framework for future clinical patient centred AMR surveillance that can inform empiric prescribing guidance and support local individual country policy decisions on future targets and ambitions. The proposal has been developed to link closely with current and planned WHO initiatives and the work of other key stakeholders. The project includes an early pilot phase, developing and testing the models in collaboration with multiple partner countries.